Business
Longevity Startup Raises Funding
Retro Biosciences, a longevity startup backed by Sam Altman, has secured $1.8 billion in new funding. The company is valued at $1.8 billion following the latest round of investment.
Coverage timeline — 1 article
STAT News
Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion valuation, it announced Friday.
2026-05-22 11:00 UTC